- Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.
- This study provides further evidence of the importance of identifying risk and initiating treatment to prevent bone loss and fractures in stroke survivors who are at increased risk of osteoporosis.
Embargoed until 4 a.m. CT / 5 a.m. ET Thursday, April 25, 2019
DALLAS, April 25, 2019 — The majority of stroke survivors are not screened or treated for osteoporosis, broken bones, or fall risk — despite stroke being a risk factor for these conditions. The risk is up to four times greater than in healthy people, according to new research in the American Heart Association’s journal Stroke.
Stroke survivors often face reduced mobility — a trait that decreases bone mineral density and increases risk for bone breaks.
Less than one-third of older women living in the United States are screened for osteoporosis and the treatment rate for some high-risk patients tops out at 30 percent.
“Our study adds to previous research that found despite an increased risk, only a small number of people who have recently had a stroke are tested and treated for osteoporosis,” said Moira Kapral, M.D., M.Sc., FRCPC, lead author of the study and professor of medicine and director of the division of general internal medicine at the University of Toronto in Canada.
Researchers identified stroke survivors age 65 and older who either had visited the emergency department or had been hospitalized for strokes (ischemic or intracerebral hemorrhage) between July 1, 2003 and March 31, 2013 at 11 regional stroke centers throughout Ontario, Canada from the Ontario Stroke Registry. Using administrative databases allowed researchers to link the registry with information about bone mineral density testing, prescription medications and deaths.
Of the 16,581 stroke survivors included in the study, only:
- 5.1 percent had bone mineral density testing;
- 15.5 percent were prescribed medications for osteoporosis within one year after stroke; and
- a small percentage of stroke survivors were prescribed medications for osteoporosis for the first time.
The study also found that, while overall screening and treatment for osteoporosis and related conditions was low, certain stroke survivors were more likely to have bone mineral density testing. These people tended to be younger, female and to have had low-trauma fractures in the year after their stroke. Patients were more likely to be prescribed medications for osteoporosis post-stroke if they were female, already had osteoporosis, had previously broken bones, had previously had bone mineral density testing and had fallen or broken bones after their stroke.
“This study offers more evidence that there is a missed opportunity to identify people with stroke at increased risk of fractures, and to initiate treatment to prevent bone loss and fractures,” Kapral said.
Co-authors are Eshita Kapoor, H.B.Sc.; Peter C. Austin, Ph.D.; Shabbir M. H. Alibhai, M.D., M.Sc.; Angela Cheung, M.D., Ph.D.; Peter Cram, M.D., M.B.A.; Leanna K. Casaubon, M.D., M.Sc.; Jiming Fang, Ph.D.; Joan Porter, M.Sc.; Eric E. Smith, M.D., Ph.D.; Marla Prager, M.D.; and Moira K. Kapral, M.D., M.Sc. Author disclosures are on the manuscript.
The Heart and Stroke Foundation of Canada funded the study.
- Available multimedia is on right column of release link - https://newsroom.heart.org/news/many-stroke-patients-not-screened-for-osteoporosis-despite-known-risks?preview=658a948047156662b7751656b027af30
- After April 25, view the manuscript online.
- ACC/AHA Guidance for Preventing Heart Disease, Stroke Released
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Karen Astle: 214-706-1392; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)